GB PHARMA ApS: Financial statements 2016
CVR: 36054220
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
GB PHARMA ApS (CVR 36054220) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -425,648 and a net result of DKK -664,356. Equity in the 2016 report amounted to DKK -2,686,576.
- Gross Profit
- DKK -425,648
- Profit/Loss
- DKK -664,356
- Equity
- DKK -2,686,576
- Total Assets
- DKK 203,867
Official annual report
Find more companies like GB PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
GB PHARMA ApS has published its interim report for the period July 28, 2014 – December 31, 2015.
As of May 26, 2016, Benny Roland Eriksen has left the board of directors of GB PHARMA ApS.
As of May 26, 2016, Gunnar Kjems is registered as adm. dir. of GB PHARMA ApS.
As of May 26, 2016, Benny Roland Eriksen has stepped down as adm. dir. of GB PHARMA ApS.
About GB PHARMA ApS
GB PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2014. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Gunnar Kjems. The board consists of Gunnar Kjems (chair). The company is owned by Gunnar Kjems. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -10,000 and a net result of DKK 31,613 compared with DKK -4,949 the year before. Equity in the 2025 report amounted to DKK -1,902,842.